Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evoke Pharma

4.69
+1.0629.20%
Post-market: 4.69-0.00010.00%19:59 EDT
Volume:355.37K
Turnover:1.57M
Market Cap:7.00M
PE:-2.17
High:5.06
Open:3.50
Low:3.43
Close:3.63
Loading ...
Jul 09, 2025

Major Issues Report

Form 8-K - Current report
May 22, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2025

Major Issues Report

Form 8-K - Current report
Mar 14, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2025

Major Issues Report

Form 8-K - Current report
Feb 24, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 29, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 28, 2024

Major Issues Report

Form 8-K - Current report
Oct 22, 2024

Major Issues Report

Form 8-K - Current report
Oct 17, 2024

Major Issues Report

Form 8-K - Current report
Oct 01, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Sep 27, 2024

Major Issues Report

Form 8-K - Current report
Sep 20, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Sep 04, 2024

Correspondence

Form CORRESP - Correspondence